Skip to main content
SpringerLink
Log in

Screening aberrant methylation profile in esophageal squamous cell carcinoma for Kazakhs in Xinjiang area of China

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

To screen the aberrant methylation genes in esophageal squamous cell carcinoma (ESCC) for Kazakh nationality in Xinjiang, and the aberrant DNA methylation genes pattern provides a clue for deeply study on ESCC mechanism. Illumina Human Methylation 450 K chip was used to screen the genome-wide methylation on six cancer tissues and six adjacent normal tissues of ESCC in Kazakh people. Meanwhile, mRNA library was constructed by scanning the RNA expression on two cancer tissues and two adjacent normal tissues by Hiseq2000. After association study between the methylation profile and expression profile, aberrant DNA methylated genes were screened out and were uploaded to the GoMiner and the KEGG, completing the bioinformatic analysis. There were 227 hypermethylation genes and 6 hypomethylated genes in cancer tissue, mRNA expression varied from 0.0312 to 8,192 in cancer tissues compared with 0.0312–1,024 in adjacent normal tissues. The correlation study indicated that there were 10 loci in 10 down-regulated genes of hypermethylated in negative correlation group. Additionally, there were 11 loci in 10 up-regulated genes in negative group. Using GoMiner to do GO analysis on aberrant DNA methylation genes, RAPGEFL1, TP53AIP1, KIAA1522, DUOXA2 were identified not involved in any biological processes. ALDH1L1 participated in folinic acid catabolism and CAPN1 positively regulated the cell proliferation. And ALDH1L1 involved in one carbon metabolism and CAPN1 participate in the apoptosis process by applying pathway analysis. The aberrant DNA methylation profiles were established and provided a clue for deeply study on ESCC of Kazakh nationality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Zhao FJ, Yun MY, Zhang Y, Xu Y (2009) The research progress of esophageal cancer in Xinjiang Kazakh. J Cent Univ Natl (Nat Sci Ed) 18(3):85–90

  2. Chen XC, LJ Pang, Li F (2007) The research progress of esophageal cancer in Xinjiang Kazakh. J Nongken Med 28(5):384–387

    CAS  Google Scholar 

  3. Liu L, Zhang JP, Li H, Jiang XF, Chen Y, Li XM, Chen HM, Zhao XX, Li HW (2010) Construction of cdc42 gene and promoter CpG island of Hazak’s esophageal cancer in Eukaryotic Expression Vector. J Xinjiang Med Univ 33(007):735–738

    CAS  Google Scholar 

  4. Yu WW, Wang LD, Qi YJ, Du F, Wang ZQ, Gao SS, He X, Fan ZM (2006) Detection of p16 gene deletion and methylation in esophageal squamous cell carcinoma tissue. J Zhengzhou Univ (Med Sci) 41(002):282–284

    CAS  Google Scholar 

  5. Lee EJ, Lee BB, Kim JW, Shim YM, Hoseok I, Han J, Cho EY, Park J, Kim DH (2006) Aberrant methylation of fragile histidine triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinoma. Eur J Cancer 42(7):972–980

    Article  CAS  PubMed  Google Scholar 

  6. Cong DG, Wang SF (2008) Hypermethylation of promoter region of RAS association domain family gene1A in esophageal squamous cell carcinoma and significance thereof. Natl Med J China 87(41):2932–2934

    Google Scholar 

  7. Ge H (2007) The Association between the polymorphisms, the promoter hypermethylation of the CpG island of the p73, PTEN and the carcinogenesis and development of ESCC. Hebei Medical University, Shijiazhuang

    Google Scholar 

  8. Vasavi M, Ponnala S, Gujjari K, Boddu P, Bharatula RS, Prasad R, Ahuja YR, Hasan Q (2006) DNA methylation in esophageal diseases including cancer: special reference to hmlh1 gene promoter status. Tumori 92(2):155–162

    CAS  PubMed  Google Scholar 

  9. Adorj NP, Distler J, Lipscher E, Model F, Müller J, Pelet C, Braun A, Florl AR, Gütig D, Grabs G, Howe A, Kursar M, Lesche R, Leu E, Lewin A, Maier S, Müller V, Otto T, Scholz C, Schulz WA, Seifert HH, Schwope I, Ziebarth H, Berlin K, Piepenbrock C, Olek A (2002) Tumour class prediction and discovery by microarray-based DNA methylation analysis. Nucleic Acids Res 30(5):e21–e27

    Article  Google Scholar 

  10. Lv H (2007) A study on methylation difference between human large cell lung cancer cell lines with different metastatic potential. Sichuan University, Chengdu

    Google Scholar 

  11. Ibanezde C, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, Cairns P (2006) Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res 66(10):5021–5028

    Article  Google Scholar 

  12. Dannenberg L, Edeberg H (2006) Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation. BMC Genomics 7(1):181–187

    Article  PubMed Central  PubMed  Google Scholar 

  13. Oleink NV, Krupenko NI, Krupenko SA (2011) Epigenetic silencing of aldh1l1, a metabolic regulator of cellular proliferation, in cancers. Genes Cancer 2(2):130–139

    Article  Google Scholar 

  14. Hwang PH, Lian L, Zacras AI (2012) Alcohol intake and folate antagonism via cyp2e1 and aldh1: effects on oral carcinogenesis. Med Hypotheses 78(2):197–202

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Salehin D, Fromberg I, Haugk C, Dohmen B, Georg T, Bohle RM, Bauerschlag D, Thill M, Friedrich M (2011) Immunhistochemical analysis for expression of calpain 1, calpain 2 and calpastatin in ovarian cancer. Eur J Gynaecol Oncol 32(6):628

    CAS  PubMed  Google Scholar 

  16. Zhang P, Wang SK, Sun GJ (2011) Research progress in association of food and nutrition with esophageal cancer. Tumor 31(8):768–771

    CAS  Google Scholar 

  17. Tang HL, Su Q (2008) Association analyses between Ca2+ signal and apoptosis. J Nanhua Univ (Med Sci) 34(5):663–666

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Toxicology, The College of Public Health, Xinjiang Medical University, Ürümqi, 830011, China

    Yan Chen, Lei Li & Wei Tian

  2. Xinjiang Institute for Esophageal Cancer Research, Ürümqi, 830011, China

    Yan Chen & Yan-chao Deng

  3. Department of Stomach and Intestinal Surgery, The Affiliated Tumor Hospital, Xinjiang Medical University, Ürümqi, China

    Dong Yin

  4. Department of Thoracic Surgery, The First Affilated Hospital, Xinjiang Medical University, Ürümqi, 830011, China

    Yan-chao Deng

Authors
  1. Yan Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dong Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yan-chao Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wei Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yan Chen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, Y., Yin, D., Li, L. et al. Screening aberrant methylation profile in esophageal squamous cell carcinoma for Kazakhs in Xinjiang area of China. Mol Biol Rep 42, 457–464 (2015). https://doi.org/10.1007/s11033-014-3788-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-014-3788-z

Keywords

Search

Navigation